The absence of DAC is a chemical difference, not simply a change in package size. A study on one form cannot supply all the properties of the other. Analytical identity should therefore be specific enough to distinguish the forms. A product catalog category doesn't replace that evidence or resolve inconsistent terminology across suppliers.
Representative product imagery. Verify the physical label and lot documentation on receipt.
Growth Signaling
CJC-1295 without DAC
In stock·Ships in 1–2 business days
CJC-1295 without DAC research material supplied with batch-level documentation. Each unit is labeled with a traceable lot code and links to its corresponding analytical report.
Select size2 options
Select pack sizeSave 18% on kits
1 × 5 mg$53.99
In stockSelected size 5 mgSC-CND5-005
Transparent volume pricing10-vial peptide kits save 18%.
Secure checkout US & EU dispatch
Research use only acknowledgment required at checkout
Report not published
Compound context
What researchers study
CJC-1295 without DAC is a catalog designation used for a GHRH related research peptide without the DAC modification. Because naming conventions vary, the exact sequence should be confirmed before selecting a reference. This listing provides the available research quantities. It should not be treated as the same experimental material as a with DAC preparation.
Many discussions associate no DAC material with modified GRF 1-29. That shorthand is useful only when the sequence documentation agrees. Published prolonged exposure findings for CJC-1295 with DAC do not establish the duration of this material. A label comparison needs chemical details as well as the name printed at the top of the page.
A GHRH receptor assay can investigate a signaling response under a specific set of conditions. It cannot independently establish persistence in a whole organism. Receptor expression and degradation during the assay can change apparent potency. Record the preparation time and assay interval when comparing independent lots or a modified sequence with another reference.
Scope limitUse the lot report to resolve sequence and modification identity. Research material is not supplied for personal dosing or treatment. Clarify ambiguous CJC naming before applying a literature method to an experiment.
Serenity Compounds is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act.
Common laboratory focus
Modified GRF 1-29 refers to a sequence context that should be stated explicitly in a method. An abbreviation can conceal differences in substitutions or terminal groups. Expected molecular weight and sequence related analytical data can help resolve those differences. Match the research material to the required analyte before interpreting a receptor response curve.
Including a reference ligand helps establish that the system can produce the expected signal. Vehicle conditions show whether the sample matrix contributes to the response. Repeated measurements then address reproducibility. CJC 1295 no dac searches often mix identity with administration claims, but neither those claims nor a clean chromatogram establish a human protocol.
Quality documentation
Know what your laboratory receives.
Batch records are published for transparency and should be independently reviewed by qualified research personnel.
Current certificateCJC-1295 without DAC · Report not publishedSee original reportView report
- Tamper-evident packaging
- Lot and SKU traceability
- Independent analytical review
Continue exploring
